1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Summary statistics for the whole study population
Studies (No.) Total Subjects (No.) Summary Statistic Mean age (yr) 30 1409 61.4 Male sex (No.) (%) 30 1409 895 (64%) Cognitive impairment (No.) (%) 30 1409 1095 (78%) FBDS (No.) (%) 27 1252 639 (51%) Other seizures (No.) (%) 28 1368 989 (72%) Psychiatric symptoms (No.) (%) 25 1203 612 (51%) Hallucinations (No.) (%) 9 493 80 (16%) Hyponatremia (No.) (%) 24 1146 512 (45%) Sleep disorder (No.) (%) 21 1166 417 (36%) Consciousness impairment (No.) (%) 12 574 180 (31%) Autonomic dysfunction (No.) (%) 15 812 155 (19%) Abnormal EEG findings (No.) (%) 19 698 508 (73%) CSF antibody positivity (No.) (%) 14 713 457 (64%)